Table 1

Positivity rate of both AC and NSCLC-NOS histology cases

Biomarker	Result	AC		NSCLC-NOS		P value*	AC+NSCLC-NOS
Biomarker	Result	n	%	n	%	P value*	n	%
ALK	Positive	79	3.4	6	2.9	0.854	85	3.4
ALK	Negative	2232	96.6	200	97.1	0.854	2432	96.6
EGFR	Positive	387	14.6	7	2.8	<0.001	394	13.6
EGFR	Negative	2261	85.4	244	97.2	<0.001	2505	86.4
PD-L1	Positive	822	48.7	91	54.2	0.204	913	49.2
PD-L1	Negative	866	51.3	77	45.8	0.204	943	50.8
ROS1	Positive	33	2.0	2	1.5	0.909	35	2.0
ROS1	Negative	1585	98.0	132	98.5	0.909	1717	98.0

*P value determined by the χ² test.
AC, adenocarcinoma; ALK, anaplastic lymphoma kinase; EGFR, epidermal growth factor receptor; NSCLC-NOS, non-small cell lung cancer–not otherwise specified; PD-L1, programmed death ligand-1; ROS1, c-ros oncogene 1.